Results
Shelter Pharma H1 FY27 Revenue Up 35.6% to ₹451.3 Million
Board approved un-audited standalone financial results for H1 FY27 ended September 30, 2026, reporting revenue of ₹451.3 million, up 35.6% YoY.
PAT increased 15.4% YoY to ₹51.9 million with an EBITDA
